RIL
MYGN icon

Rothschild Investment LLC’s Myriad Genetics MYGN Stock Holding History

Rothschild Investment LLC’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.52K Buy
337
+66
+24% +$344 ﹤0.01% 2679
2025
Q4 		$1.67K Buy
271
+47
+21% +$341 ﹤0.01% 2462
2025
Q3 		$1.62K Buy
+224
New +$1.33K ﹤0.01% 2358
2025
Q2 		– Sell
-105
Closed -$931 – 3131
2025
Q1 		$931 Buy
105
+75
+250% +$901 ﹤0.01% 2381
2024
Q4 		$411 Sell
30
-60
-67% -$1.11K ﹤0.01% 2607
2024
Q3 		$2.46K Buy
90
+55
+157% +$1.49K ﹤0.01% 1619
2024
Q2 		$856 Buy
35
+25
+250% +$549 ﹤0.01% 1742
2024
Q1 		$213 Buy
+10
New +$215 ﹤0.01% 1720

Other funds holding MYGN

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return